Issue is its phase 2 trials mate, do you think holders want to wait another god knows how long to phase 3 trials. Theyll probably need to raise more to be able to fund the trials.
Im holding a phase 3 company which is fully funded all the way to results and is 1/14th of the market cap of PAR, given TAM is lower, there results are due in 1 year and a half or so. I see much better investments out there in the bio space than this one at the moment, hence why my money is elsewhere
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-51
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |